You have 9 free searches left this month | for more free features.

Condition

Diabetic Macular Edema (1)

Thyroid Associated Ophthalmopathies (1)

Thyroid Eye Disease (1)

Thyroid-Associated Ophthalmopathy (1)

Overall Status

Completed (2)

Recruiting (1)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

phase 4 (1)

Sponsor

Horizon Pharma USA, Inc. (1)

Horizon Therapeutics USA, Inc. (1)

River Vision Development Corporation (1)

Collaborator

Intervention

teprotumumab (3)

normal saline (1)

placebo (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

teprotumumab

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Thyroid Eye Disease Trial in Worldwide (Teprotumumab, Placebo)

Recruiting

Thyroid Eye Disease

Teprotumumab
Placebo

Los Angeles, California
+28 more

Jan 19, 2023

Thyroid Associated Ophthalmopathies, Thyroid-Associated Ophthalmopathy Trial in Worldwide (teprotumumab, normal saline)

Completed

Has Results

Thyroid Associated Ophthalmopathies
Thyroid-Associated Ophthalmopathy

teprotumumab
normal saline

Los Angeles, California
+14 more

Mar 27, 2018

Diabetic Macular Edema Trial in Beverley Hills, St. Petersburg, Omaha (Teprotumumab)

Completed

Diabetic Macular Edema

Teprotumumab

Beverley Hills, California
+2 more

Aug 17, 2016